154 related articles for article (PubMed ID: 10801059)
41. The metabolism of glucocerebrosides - From 1965 to the present.
Futerman AH; Platt FM
Mol Genet Metab; 2017; 120(1-2):22-26. PubMed ID: 27955980
[TBL] [Abstract][Full Text] [Related]
42. Glucosylceramide mimics: highly potent GCase inhibitors and selective pharmacological chaperones for mutations associated with types 1 and 2 Gaucher disease.
Schönemann W; Gallienne E; Ikeda-Obatake K; Asano N; Nakagawa S; Kato A; Adachi I; Górecki M; Frelek J; Martin OR
ChemMedChem; 2013 Nov; 8(11):1805-17. PubMed ID: 24115322
[TBL] [Abstract][Full Text] [Related]
43. Clinical phenotype of Gaucher disease in relation to properties of mutant glucocerebrosidase in cultured fibroblasts.
Van Weely S; Van Leeuwen MB; Jansen ID; De Bruijn MA; Brouwer-Kelder EM; Schram AW; Sa Miranda MC; Barranger JA; Petersen EM; Goldblatt J
Biochim Biophys Acta; 1991 Jun; 1096(4):301-11. PubMed ID: 1829642
[TBL] [Abstract][Full Text] [Related]
44. Inhibitors and stimulators of glucocerebroside metabolism.
Radin NS
Prog Clin Biol Res; 1982; 95():357-83. PubMed ID: 6214799
[No Abstract] [Full Text] [Related]
45. A new glucocerebrosidase-deficient neuronal cell model provides a tool to probe pathophysiology and therapeutics for Gaucher disease.
Westbroek W; Nguyen M; Siebert M; Lindstrom T; Burnett RA; Aflaki E; Jung O; Tamargo R; Rodriguez-Gil JL; Acosta W; Hendrix A; Behre B; Tayebi N; Fujiwara H; Sidhu R; Renvoise B; Ginns EI; Dutra A; Pak E; Cramer C; Ory DS; Pavan WJ; Sidransky E
Dis Model Mech; 2016 Jul; 9(7):769-78. PubMed ID: 27482815
[TBL] [Abstract][Full Text] [Related]
46. [A retrospective study on enzyme replacement therapy in patients with Gaucher disease].
Duan YL; Zhang YH; Zang Y; Shi HP; Zhang WM; Hu YM
Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):653-6. PubMed ID: 17217655
[TBL] [Abstract][Full Text] [Related]
47. Development of a panel of highly sensitive, equivalent assays for detection of antibody responses to velaglucerase alfa or imiglucerase enzyme replacement therapy in patients with Gaucher disease.
Séllos-Moura M; Barzegar S; Pan L; Shi P; Oommen S; Durant J; Ruiz JA
J Immunol Methods; 2011 Oct; 373(1-2):45-53. PubMed ID: 21846471
[TBL] [Abstract][Full Text] [Related]
48. Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients.
Chang HH; Asano N; Ishii S; Ichikawa Y; Fan JQ
FEBS J; 2006 Sep; 273(17):4082-92. PubMed ID: 16934036
[TBL] [Abstract][Full Text] [Related]
49. Glucocerebrosidase deficiency dramatically impairs human bone marrow haematopoiesis in an in vitro model of Gaucher disease.
Berger J; Lecourt S; Vanneaux V; Rapatel C; Boisgard S; Caillaud C; Boiret-Dupré N; Chomienne C; Marolleau JP; Larghero J; Berger MG
Br J Haematol; 2010 Jul; 150(1):93-101. PubMed ID: 20507316
[TBL] [Abstract][Full Text] [Related]
50. Emerging therapeutic targets for Gaucher disease.
Vitner EB; Vardi A; Cox TM; Futerman AH
Expert Opin Ther Targets; 2015 Mar; 19(3):321-34. PubMed ID: 25416676
[TBL] [Abstract][Full Text] [Related]
51. Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: a biological link between Gaucher disease and parkinsonism.
Manning-Boğ AB; Schüle B; Langston JW
Neurotoxicology; 2009 Nov; 30(6):1127-32. PubMed ID: 19576930
[TBL] [Abstract][Full Text] [Related]
52. Assay of glucocerebrosidase using a fluorescent analogue of glucocerebroside for the diagnosis of Gaucher disease.
Midorikawa M; Okada S; Yutaka T; Yabuuchi H; Naoi M; Kiuchi K; Yagi K
Biochem Int; 1985 Sep; 11(3):327-32. PubMed ID: 4062951
[TBL] [Abstract][Full Text] [Related]
53. Animal and cellular models of Gaucher's disease. I. Refractoriness of thio analogs of glucocerebroside to enzymatic hydrolysis.
Quirk JM; Weis AL; Shapiro D; Brady RO
Biotechnol Appl Biochem; 1986 Feb; 8(1):96-100. PubMed ID: 3828086
[TBL] [Abstract][Full Text] [Related]
54. Coenzyme Q
de la Mata M; Cotán D; Oropesa-Ávila M; Villanueva-Paz M; de Lavera I; Álvarez-Córdoba M; Luzón-Hidalgo R; Suárez-Rivero JM; Tiscornia G; Sánchez-Alcázar JA
Orphanet J Rare Dis; 2017 Feb; 12(1):23. PubMed ID: 28166796
[TBL] [Abstract][Full Text] [Related]
55. A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase.
Pastores GM; Petakov M; Giraldo P; Rosenbaum H; Szer J; Deegan PB; Amato DJ; Mengel E; Tan ES; Chertkoff R; Brill-Almon E; Zimran A
Blood Cells Mol Dis; 2014 Dec; 53(4):253-60. PubMed ID: 24950666
[TBL] [Abstract][Full Text] [Related]
56. A revised fluorometric assay for Gaucher's disease using conduritol-beta-epoxide with liver as the source of Beta-glucosidase.
Daniels LB; Glew RH; Radin NS; Vunnam RR
Clin Chim Acta; 1980 Sep; 106(2):155-63. PubMed ID: 6773704
[TBL] [Abstract][Full Text] [Related]
57. Demonstration of feasibility of in vivo gene therapy for Gaucher disease using a chemically induced mouse model.
Marshall J; McEachern KA; Kyros JA; Nietupski JB; Budzinski T; Ziegler RJ; Yew NS; Sullivan J; Scaria A; van Rooijen N; Barranger JA; Cheng SH
Mol Ther; 2002 Aug; 6(2):179-89. PubMed ID: 12161184
[TBL] [Abstract][Full Text] [Related]
58. Ubiquitous transgene expression of the glucosylceramide-synthesizing enzyme accelerates glucosylceramide accumulation and storage cells in a Gaucher disease mouse model.
Barnes S; Xu YH; Zhang W; Liou B; Setchell KD; Bao L; Grabowski GA; Sun Y
PLoS One; 2014; 9(12):e116023. PubMed ID: 25551612
[TBL] [Abstract][Full Text] [Related]
59. Gaucher disease: a century of delineation and research. Enzyme replacement therapy: model and clinical studies.
Beutler E; Dale GL
Prog Clin Biol Res; 1982; 95():703-16. PubMed ID: 7122644
[TBL] [Abstract][Full Text] [Related]
60. Cholesterol glucosylation is catalyzed by transglucosylation reaction of β-glucosidase 1.
Akiyama H; Kobayashi S; Hirabayashi Y; Murakami-Murofushi K
Biochem Biophys Res Commun; 2013 Nov; 441(4):838-43. PubMed ID: 24211208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
